SEC Contract Filing

Filing Date: 2019-11-14

Document Content:
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>embi_ex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head><title>embi_ex103.htm</title><!--Document Created by EDGARMaster--></head><BODY spellcheck="true" style="text-align:justify;font:10pt TIMES NEW ROMAN;margin:0px 7%"><p style="MARGIN: 0px" align="right"><b>EXHIBIT 10.3</b></p><p style="MARGIN: 0px">&nbsp;</p><b><font size="3"><p style="MARGIN: 0px">&nbsp;</p></font></b><b><font size="3"><p><img src="embi_ex103img1.jpg"></p>Master Services Agreement</font></b><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px 0px 0px 0in" align="justify"><b>Date: </b>September 20, 2019</p><p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p><p style="FONT-SIZE: 2px; HEIGHT: 2px; WIDTH: 100%; BACKGROUND: #000000; MARGIN: 0px" name="hrule">&nbsp;</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px">Parties</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px 0px 0px 28.35pt; TEXT-INDENT: 0px" align="justify"><b>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Novotech (Australia) Pty Limited</b> ACN 071 874 881 of Level 3, 235 Pyrmont Street, Pyrmont, NSW 2009, Australia (<b>Novotech</b>)</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px 0px 0px 28.35pt; TEXT-INDENT: 0px" align="justify"><b>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>EMBI Australia Pty Ltd </b>ACN 635 424 047, a company incorporated in Victoria, Australia, having its principal place of business at 58 Gipps Street, Collingwood, 3066 Vic, Australia, (<b>Sponsor</b>)</p><p style="MARGIN: 0px 0px 0px 28.35pt; TEXT-INDENT: 0px" align="justify">&nbsp;</p><p style="FONT-SIZE: 2px; HEIGHT: 2px; WIDTH: 100%; BACKGROUND: #000000; MARGIN: 0px" name="hrule">&nbsp;</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px">Background</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">A&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Novotech is a clinical research organization engaged in the business of providing clinical management, data management, biostatistical, medical monitoring, quality assurance, regulatory, site management organisation, central laboratory and other related services to support clinical trials.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">B&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sponsor is an organization engaged in the business of developing pharmaceutical, biotechnology, and/or device products for human therapeutic use.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">C&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sponsor would like to retain the services of Novotech from time to time to perform clinical research and related services in connection with certain clinical research projects Sponsor is conducting as set out in a project agreement pursuant to the terms of this Agreement.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">D&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Novotech is willing to provide services to Sponsor in accordance with the terms and conditions of this Agreement.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">The Parties hereby agree as follows:</p><p style="MARGIN: 0px" align="justify">&nbsp;</p><p style="FONT-SIZE: 2px; HEIGHT: 2px; WIDTH: 100%; BACKGROUND: #000000; MARGIN: 0px" name="hrule">&nbsp;</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Defined terms and interpretation</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify"><u>Defined terms</u></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In this Agreement, any capitalised terms that are not defined have the meaning given to them below:</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify"><b>Affiliate </b>means any entity under common control, controlled by or which controls a Party. Control of an entity includes the power to directly:</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">(a) determine the financial or operating policies of the entity;</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">(b) control the membership of the board or other governing body of the entity; or</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify">(c) control the casting of more than one half of the maximum number of votes that may be cast at a general meeting of the entity,</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify"><b>Claim</b> means an allegation, debt, cause of action, liability, claim, proceeding, suit or demand of any nature however arising, whether present or future, fixed or not, actual or contingent.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="justify"><b>Confidential Information</b> means all confidential or proprietary information whether in visual, documentary, oral or electronic form which includes systems, process and procedures, in respect of the Discloser, made available to the Recipient (whether disclosed orally or disclosed or accessed in written, electronic or other form or media, and whether or not marked, designated or otherwise identified as "confidential"), unless expressly agreed in writing not to be confidential. </p><p style="MARGIN: 0px">&nbsp;<table id="pagebreakc82428ff-dd1a-4665-a3cf-80d1c3b82242" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"><tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: right">Page 1 of 12</td></tr><tr><td><div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr><tr><td>&nbsp;</td></tr></table></p><p style="MARGIN: 0px">&nbsp;<img src="embi_ex103img1.jpg"></p><p style="MARGIN: 0px" align="jus